IGC Pharma
30 hedge funds and large institutions have $1.36M invested in IGC Pharma in 2025 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
Holders
30
Holding in Top 10
–
Calls
$1K
Puts
–
Top Buyers
| 1 | +$50.3K | |
| 2 | +$14.5K | |
| 3 | +$6K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.86K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.64K |
Top Sellers
| 1 | -$125K | |
| 2 | -$107K | |
| 3 | -$37K | |
| 4 |
HF
HRT Financial
New York
|
-$25K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$14.6K |
